ProCE Banner Activity

Ключевые исследования ВИЧ, повлиявшие на мою работу, по итогам IDWeek и HIV Glasgow 2022*

Slideset Download
Conference Coverage

Ознакомьтесь с обзорами ключевых исследований ВИЧ по итогам IDWeek и HIV Glasgow 2022, составленными экспертным профессорским составом, включая результаты исследований стратегий профилактики, длительного лечения, ежедневного перорального лечения, экспериментальных препаратов и взаимодействия ВИЧ и COVID-19.

Released: December 16, 2022

Share

Faculty

Joseph J. Eron, Jr.

Joseph J. Eron, Jr., MD

Professor of Medicine, School of Medicine
Herman and Louise Smith Distinguished Professor
Chief, Division of Infectious Diseases
Director, Clinical Core, UNC Center for AIDS Research
Adjunct Professor of Epidemiology
Gillings School of Global Public Health
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Karine Lacombe

Karine Lacombe, MD, PhD

Professor of Medicine
Infectious Diseases Department
Sorbonne Uiversité
Inserm Pierre Louis School of Public Health
Paris, France

Chloe Orkin

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Dean for Healthcare Transformation
Queen Mary University of London
Faculty of Medicine and Dentistry
London, United Kingdom

Babafemi Taiwo

Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Chief, Division of Infectious Diseases
Northwestern University
Chicago, Illinois

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Faculty Disclosure

Primary Author

Joseph J. Eron, Jr., MD

Professor of Medicine, School of Medicine
Herman and Louise Smith Distinguished Professor
Chief, Division of Infectious Diseases
Director, Clinical Core, UNC Center for AIDS Research
Adjunct Professor of Epidemiology
Gillings School of Global Public Health
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Джозеф Дж. Эрон-младший, доктор медицины (MD): консультант/эксперт/лектор: Gilead Sciences, GlaxoSmithKline, Janssen, Merck, ViiV Healthcare; исследователь: Gilead Sciences, ViiV Healthcare.

Karine Lacombe, MD, PhD

Professor of Medicine
Infectious Diseases Department
Sorbonne Uiversité
Inserm Pierre Louis School of Public Health
Paris, France

Карин Лакомб, доктор медицины (MD), PhD: консультант/эксперт/лектор: Gilead Sciences, GlaxoSmithKline, Janssen, MSD.

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Dean for Healthcare Transformation
Queen Mary University of London
Faculty of Medicine and Dentistry
London, United Kingdom

Chloe Orkin, MBChB, FRCP, MD: consultant/advisor/speaker: Gilead, GSK, MSD, ViiV; researcher: AstraZeneca, Gilead, GSK, MSD, ViiV.

Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Chief, Division of Infectious Diseases
Northwestern University
Chicago, Illinois

Бабафеми Тайво, бакалавр медицины и бакалавр хирургии (MBBS): консультант/эксперт/лектор: Gilead Sciences, Johnson & Johnson, ViiV Healthcare.